Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Filings indexed 422 across all filing types
Latest filing 2019-03-15 Report Publication Anno…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
감사보고서제출
Report Publication Announcement Classification · 95% confidence The document is a regulatory filing from the Korean stock exchange (KRX) titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of the audit opinion, key financial data (assets, liabilities, revenue, profit), and confirms the auditor's name. While it contains financial data, it is a short, standardized regulatory announcement notifying the market that the audit report has been submitted and is available, rather than the full annual report document itself. Therefore, it fits the 'Report Publication Announcement' (RPA) category.
2019-03-15 Korean
투자설명서
Regulatory Filings Classification · 99% confidence The document is a 'Securities Registration Statement' (투자설명서) for a corporate bond issuance (34th series of unsecured bonds) by Handok Inc. It details the issuance amount, interest rates, maturity, and risk factors associated with the bond. This type of document is a formal regulatory filing required for public offerings of securities, which falls under the 'Regulatory Filings' category as it is a specific legal disclosure document for capital raising that does not fit into the other specialized categories like 10-K or Earnings Release.
2019-03-14 Korean
증권발행실적보고서
Capital/Financing Update Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Services Commission (FSC) in South Korea. It details the issuance of corporate bonds (debt securities), including the issuance amount, underwriting details, and the use of proceeds. This type of filing is a standard regulatory disclosure regarding capital raising activities, which falls under the 'Capital/Financing Update' category.
2019-03-14 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Handok Inc. It contains the agenda for the meeting, including reports on financial statements, election of directors, and other corporate governance matters. This type of document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their participation/votes. In the context of the provided categories, this fits best as a Proxy Solicitation & Information Statement.
2019-03-13 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the scheduling of a General Meeting of Shareholders. It specifically addresses the 'reason for holding the meeting on a concentrated date' (주주총회 집중일 개최 사유 신고). Since this is a regulatory notification regarding meeting logistics rather than the meeting materials themselves, the proxy statement, or the voting results, it falls under the general regulatory filing category.
2019-03-13 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Handok Inc. regarding the 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). It details the number of shares to be sold, the purpose of the disposal, the method (market sale), and the regulatory basis under the Capital Markets Act. Since the document specifically reports the company's decision to sell its own shares (a share buyback/disposal event), it falls under the 'Transaction in Own Shares' category.
2019-03-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.